QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Digoxin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 30 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Diphenhydramine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 200 ng/mL |
| Sample Volume: | 0.03 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Dipyridamole in presence of Acetyl Salicylic Acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 5,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Docetaxel
Paclitaxel (Taxol) (Matrix: Human Plasma)
Paclitaxel (Taxol) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 1,000 ng/mL 5 – 2,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Docetaxel
Paclitaxel (Taxol) (Matrix: Human Plasma)
Paclitaxel (Taxol) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 1,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Docetaxel
Paclitaxel (Taxol) (Matrix: Human Serum)
Paclitaxel (Taxol) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 2 – 2,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N/A |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Dolutegravir (DTG) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 20,000 ng/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Dolutegravir (DTG) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 12,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Dolutegravir (DTG) in presence of Tenofovir (TFV), Lamivudine (3TC), Abacavir (ABC), Emtricitabine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Domperidone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.3 – 50 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Gastrointestinal |
| Classification: | Drug Assays |
Donepezil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 50 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Dementia and Alzheimer’s Disease |
| Classification: | Drug Assays |
Donepezil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 40 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Dementia and Alzheimer’s Disease |
| Classification: | Drug Assays |
Donepezil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 50 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Dementia and Alzheimer’s Disease |
| Classification: | Drug Assays |
Donepezil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 20 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Dementia and Alzheimer’s Disease |
| Classification: | Drug Assays |
Donepezil (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 to 200 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Dementia and Alzheimer’s Disease |
| Classification: | Drug Assays |
Doxazosin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 20 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Doxazosin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 30 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Doxepin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 60 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Doxepin
Nor-doxepin (Matrix: Human Plasma)
Nor-doxepin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 120 ng/mL 0.1 – 60 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Doxepin
Nor-doxepin (Matrix: Human Plasma)
Nor-doxepin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.3 – 180 ng/mL 0.3 – 60 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Doxycycline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 1,500 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Doxycycline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 6,000 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Doxycycline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 2,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Doxycycline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 25.0 – 5,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Drospirenone (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.200 – 100 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Women’s Health |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
